The first ‘blueprint’ of human skeletal development reveals how the skeleton forms, shedding light on the process of arthritis, and highlighting cells involved in conditions that affect skull and bone growth.
Abbott secures FDA approval for dual-chamber leadless pacemaker
Dive Brief: Abbott received approval from the Food and Drug Administration for a dual-chamber leadless pacemaker system that the company claims is the world’s first,
July 5, 2023